XML 28 R5.htm IDEA: XBRL DOCUMENT v2.3.0.15
Consolidated Statements of Cash Flows (unaudited) (USD $)
In Thousands
9 Months Ended
Oct. 08, 2011
Oct. 09, 2010
Operating activities:  
Net earnings$ 27,625$ 34,001
Adjustments to reconcile net earnings to net cash provided by operating activities:  
Depreciation and amortization27,68827,638
Amortization of deferred financing costs1,4091,411
Non-cash convertible debt interest4,3854,058
Amortization of rebateable loans2,5683,074
Provision for bad debts683216
Provision for lease reserves631291
Deferred income tax expense3,9997,510
Loss (gain) on sale of property, plant and equipment1,316(423)
LIFO charge (credit)9,717(76)
Asset impairments363926
Share-based compensation4,2926,179
Deferred compensation646838
Other(644)(730)
Changes in operating assets and liabilities:  
Accounts and notes receivable(37,768)(22,593)
Inventories(20,973)(55,886)
Prepaid expenses(1,835)1,887
Accounts payable35,66014,407
Accrued expenses(2,637)(912)
Income taxes payable1,747(5,305)
Other assets and liabilities(3,968)(200)
Net cash provided by operating activities54,90416,311
Investing activities:  
Disposal of property, plant and equipment3,863575
Additions to property, plant and equipment(47,340)(39,853)
Business acquired, net of cash(1,587) 
Loans to customers(7,285)(1,095)
Payments from customers on loans1,1781,703
Other investing activities(520)(400)
Net cash used in investing activities(51,691)(39,070)
Financing activities:  
Proceeds (payments) of revolving debt(6,000)38,000
Dividends paid(6,549)(6,739)
Repurchase of Common Stock (20,267)
Payments of long-term debt(284)(264)
Payments of capital lease obligations(2,256)(3,009)
Increase in outstanding checks12,23514,993
Other financing activities(508) 
Net cash provided by (used in) financing activities(3,362)22,714
Net decrease in cash and cash equivalents(149)(45)
Cash and cash equivalents at beginning of period830830
Cash and cash equivalents at end of period681785
Supplemental schedule of non-cash investing and financing activities:  
Capital expenditures funded by other payables $ 8,500